ESR1 and breast carcinoma: For instance, elevated level of PIP5Kα increases expression of pSer-473 AKT and is in complexes with VEGFR2, acting as co-factor of ER-alpha to regulate activities of target genes, including cyclin D1 and CDK1, particularly in triple-negative and ER+ breast cancer cells (67).